Acceptance and Perceived Benefits of Digitalization by Medical Assistants
Launched by JACOBS UNIVERSITY BREMEN GGMBH · Feb 19, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how medical assistants feel about using digital tools, like e-prescriptions, in their daily work. The goal is to understand the challenges they face when adjusting to these new technologies and to gather their feedback after they start using them. By doing this, researchers hope to improve the way digital processes are integrated into healthcare, making it safer and more efficient for everyone involved.
To participate in this study, individuals need to be 18 years or older and able to take part in surveys in either German or English. This means that participants should be comfortable reading and understanding these languages. Those who are interested can expect to share their experiences and opinions, which will help shape the future of digital healthcare solutions. The trial is currently recruiting participants from all backgrounds, so if you or someone you know fits the criteria, this could be a great opportunity to contribute to important advancements in healthcare.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Ability to participate in surveys (e.g., sufficient German or English language skills)
- Exclusion Criteria:
- • Younger than 18 years
- • Illiteracy
- • Massively limited cognitive abilities, i.e., linguistic components of the digital offerings must be able to be used to complete questionnaires or participate in interviews
About Jacobs University Bremen Ggmbh
Jacobs University Bremen gGmbH is a distinguished private university located in Bremen, Germany, renowned for its interdisciplinary research and innovative educational programs. With a strong emphasis on international collaboration and cutting-edge scientific inquiry, the university actively engages in clinical trials that advance medical research and contribute to the development of novel therapeutic strategies. Its commitment to excellence is reflected in its robust infrastructure, diverse academic community, and partnerships with leading institutions, enabling comprehensive support for clinical research initiatives that aim to improve health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bremen, , Germany
Patients applied
Trial Officials
Alina Dahmen, Dr. med.
Study Director
Constructor University Bremen gGmbH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported